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Abstract
Deep brain stimulation (DBS) has been investigated for the treatment of epilepsy. In rodents, an increase in the latency for
the development of seizures and status epilepticus (SE) has been reported in different animal models but the consequences
of delivering stimulation to chronic epileptic animals have not been extensively addressed. We study the effects of anterior
thalamic nucleus (AN) stimulation at different current intensities in rats rendered epileptic following pilocarpine (Pilo)
administration. Four months after Pilo-induced SE, chronic epileptic rats were bilaterally implanted with AN electrodes or
had sham-surgery. Stimulation was delivered for 6 h/day, 5 days/week at 130 Hz, 90 msec. and either 100 mA or 500 mA. The
frequency of spontaneous recurrent seizures in animals receiving stimulation was compared to that recorded in the
preoperative period and in rats given sham treatment. To investigate the effects of DBS on hippocampal excitability, brain
slices from animals receiving AN DBS or sham surgery were studied with electrophysiology. We found that rats treated with
AN DBS at 100 mA had a 52% non-significant reduction in the frequency of seizures as compared to sham-treated controls
and 61% less seizures than at baseline. Animals given DBS at 500 mA had 5.1 times more seizures than controls and a 2.8
fold increase in seizure rate as compared to preoperative values. In non-stimulated controls, the average frequency of
seizures before and after surgery remained unaltered. In vitro recordings have shown that slices from animals previously
given DBS at 100 mA had a longer latency for the development of epileptiform activity, shorter and smaller DC shifts, and a
smaller spike amplitude compared to non-stimulated controls. In contrast, a higher spike amplitude was recorded in slices
from animals given AN DBS at 500 mA.
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Introduction
Approximately 30% of patients with epilepsy continue to have
seizures despite adequate medical treatment [1]. In this refractory
population, surgery often comprises an effective therapeutic
modality. Though resective procedures are still considered to be
the surgical treatment of choice, some patients are not deemed to
be good candidates because of multiple seizure foci, foci in
eloquent brain regions or foci that cannot be identified. Under
these circumstances, neuromodulation strategies represent a
potential alternative [2–4].
Deep brain stimulation (DBS) involves the delivery of current to
the brain parenchyma though implanted electrodes. Over the last
decade, a series of preclinical and clinical studies have shown that
DBS in the anterior nucleus of the thalamus (AN) reduces seizure
rate and increases the latency for the development of seizures and
status epilepticus (SE) [5–18]. To date, preclinical research in the
field has largely been conducted in naı¨ve rodents with seizures
induced through the administration of chemical or electrical
stimuli [6,8,13,14,18–20]. In the only study addressing the effects
of DBS in chronic epileptic animals, AN stimulation had a
proconvulsant effect [21].
We show that stimulation at parameters that approximate those
used in clinical practice [22,23] decreases the frequency of seizures
and is associated with a reduction in hippocampal excitability. In
contrast, DBS at high currents seems to be proconvulsant.
Materials and Methods
Protocols were approved by the Animal Care committee of the
Universidade Federal de Sa˜o Paulo (2070/09).
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Surgery and AN stimulation
Adult male Wistar rats (250–300 g) were injected with
pilocarpine (Pilo; 320 mg/Kg i.p.). Four months after Pilo-induced
SE, chronic epileptic rats were videotaped for 6 h/day, 5 days/
week for 2 weeks to register their baseline frequency of behavioral
seizures (Figure 1A). Animals were then paired according to
seizure rate and assigned to receive either DBS or sham-surgery
(holes drilled to the skull without the insertion of electrodes).
Under ketamine/xylazine anesthesia (100/7.5 mg/kg i.p.), ani-
mals in the DBS group had insulated stainless steel electrodes
(cathodes; 250 mm diameter; 0.5 mm exposed length) bilaterally
implanted in the AN (anteroposterior 21.5, lateral61.5, depth
5.2) [24]. A screw implanted over the right somatosensory cortex
was used as the anode. On the first postoperative week, the effects
of electrode insertion in the frequency of seizures were studied. On
the second postoperative week, DBS was administered for 5 days
(6 h/day) using a portable stimulator (St Jude Medical, Plano, TX)
at 130 Hz, 90 msec, and either 500 mA or 100 mA (Figure 1A).
These settings were chosen as they were either effective against
pilocarpine-induced seizures in our previous study (500 mA) [14]
or estimated to generate a charge density (current x pulse width/
area of exposed electrode) similar to that used in the clinic
(100 mA) [5,23,25]. Stimulation frequency and pulse width were in
the range of those used in clinical practice [5,7,9,10].
A blinded investigator visually scored the frequency of
behavioral seizures. Those characterized by clonic/tonic/tonic-
clonic movements of the forelimbs culminating with rearing and
falling were quantified from videotapes obtained during recording
sessions.
Electrophysiology
Prior to the experiments, different groups of chronic epileptic
rats were given 5 days of DBS at the settings described above.
Following CO2 narcosis, animals were decapitated. Their brains
were removed from the skull and 400 mm hippocampal slices were
cut on a vibratome. Slices were individually transferred to an
interface-type chamber, placed on a membrane (0.4 mm Millicell
culture plate inserts; Millipore, Badford, MA) and continuously
bathed with artificial cerebrospinal fluid (aCSF; 127 mM NaCl,
2 mM KCl, 1.5 mM MgSO4, 1.1 mM KH2PO4, 26 mM
NaHCO3, 2 mM CaCl2, and 10 mM glucose) at 33uC under a
stream of moisturized 95% O2 – 5% CO2. One hour later, slices
were perfused with a zero calcium and 8 mM potassium solution
[26].
Figure 1. Effects of DBS on the frequency of spontaneous recurrent seizures in chronic epileptic rats. (A) Four months after pilocarpine-
induced (Pilo) status epilepticus (SE), animals were videotaped for two weeks, followed by the implantation of anterior thalamic nucleus (AN)
electrodes or sham surgery. On the first postoperative week, the frequency of behavioral seizures was recorded to study the effects of surgery and
electrode insertion. On the second postoperative week, animals were given DBS (horizontal bar). (B) Animals treated with 100 mA had a 52%
reduction in seizure rate as compared to sham-treated controls (p = 0.1) and 61% less seizures than at baseline (p = 0.05). In contrast, rats given DBS at
500 mA had 5.1 times more seizures than controls (p,0.01) and a 2.8 fold increase in seizure rate as compared to preoperative values (p = 0.03). (C)
Schematic representation of coronal brain sections depicting the region in which the tips of the electrodes were identified. For clarity, we did not plot
the tip of each of the 58 electrodes implanted in animals receiving stimulation but rather indicate the boundaries of the regions in which they were
identified (circles). Values in B are presented as mean and SE. Numbers in parenthesis represent animals per group. In C, numbers on the right denote
distance from the bregma. AD- anterodorsal nucleus of the thalamus; AV- anteroventral nucleus of the thalamus; AM- anteromedial nucleus of the
thalamus. * statistically significant compared to preoperative values. 1 statistically significant compared to controls. Figure C was modified and
reprinted from Paxinos and Watson, Copyright (1998) with permission from Elsevier.
doi:10.1371/journal.pone.0097618.g001
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Extracellular field potentials were recorded from the hippo-
campal dentate gyrus (DG). Recording electrodes were made of
microfilament capillary thin-walled glass (Clark Electromedical
Instruments, GC150F-10) pulled with a DMZ-Universal Puller
(Zeitz-Instruments, Germany). Electrodes were filled with 1 M
NaCl (4–10 MV), connected to a head stage (model AI 402650,
ultralow noise amplifier – Axon Instruments, USA) and a biological
amplifier (model Cyberamp 380 – Axon Instruments, USA).
Recorded signals were filtered (3 kHz lowpass) and digitized
(sampling frequency of 10 kHz) before the analysis.
For each group, slices containing the dorsal hippocampus of 5–9
animals were analyzed (2–3 slices per animal). After the
development of epileptiform discharges, recordings were carried
out for 20 minutes. The following parameters were considered for
analysis: 1) Latency to record epileptiform discharges from the
moment the bath was perfused with a zero calcium high potassium
solution; 2) duration and amplitude of DC shifts; and 3) the
amplitude of population spikes. A digital Fourier transform was
used to quantify DC-shifts. Once in the frequency domain, the
event signal was recalculated taking into account only components
below 10 Hz. This process has allowed the analysis of DC shifts
without the interference of population spikes. Event duration was
calculated by subtracting the final time from the initial time of an
event [26].
Statistical Analysis and histology
ANOVA (Tukey post-hoc) was used to compare the frequency
of seizures across groups. Comparisons between pairs of either
animals given DBS at 100 mA and controls or the pre and
postoperative frequency of seizures was carried out with a paired t-
test. Mann Whitney U or Kruskall Wallis tests were used for the
analysis of electrophysiology data. A Fisher exact test was used to
compare proportions. Statistical significance was considered when
p#0.05. Only animals with electrodes implanted in the AN, as
confirmed with cresyl-violet staining, were included in this study
(Figure 1C). Our initial plan was to have 25 controls, 25 rats in the
100 mA DBS group and 10 animals in the group given DBS at
500 mA. We have missed the target in 3 animals receiving 100 mA
(one rat had an electrode placed in the AN and the other in the
ventral anterior nucleus, one rat had electrodes bilaterally
implanted in the medial dorsal nucleus, and one rat had electrodes
bilaterally placed in the dentate gyrus). These animals were
excluded from the analysis along with their corresponding
controls. One rat from the DBS 500 mA group has also been
excluded due to misplaced electrodes (one electrode placed in the
AN and the other in the ventral anterior nucleus). Aside from
misplaced electrodes, two animals have died in the course of the
experiments (one control and one rat from the DBS 100 mA
group). Their mates were also excluded from the study. Due to all
these losses, we ended our experiments with 20 animals in the
groups receiving 100 mA DBS and sham treatment and 9 in the
group treated with 500 mA.
Results
Effects of AN DBS in vivo
Our first experiment consisted in characterizing the effects of
AN DBS against spontaneous recurrent seizures in vivo. Overall,
we found that stimulation at 100 mA reduced seizure rate whereas
500 mA was proconvulsant (p,0.01). The proportion of animals
that had a change in the frequency of seizures after surgery was
also different across groups (p,0.01). In non-stimulated epileptic
controls (n = 20), the average frequency of seizures before and after
surgery remained unchanged (Figure 1B). In addition, when each
animal was considered individually, we found that a similar
proportion of rats had an increase (n = 7; 35%), a decrease (n = 7;
35%), or no change in the frequency of seizures before and after
surgery (n = 6; 30%; Table S1).
Rats treated with AN DBS at 100 mA (n = 20) had a 52%
reduction in the frequency of seizures as compared to sham-
treated controls (p = 0.1) and 61% less seizures than at baseline
(p = 0.05) (Figure 1B). Of the 20 animals treated, 12 (60%) had a
decrease in seizure rate, 5 (15%) had the same number of seizures
before and after DBS and 3 (10%) had an increase in the
frequency of seizures while receiving stimulation (Table S1).
Animals given DBS at 500 mA (n = 9) had 5.1 times more
seizures than controls (p,0.01) and a 2.8 fold increase in seizure
rate as compared to preoperative values (p = 0.03) (Figure 1B). In
this group, 8 of the animals treated with DBS (89%) had an
increase in the number of seizures while receiving stimulation. In
one animal (11%), the frequency of seizures in the postoperative
period remained unchanged (Table S1).
Effects of AN DBS in vitro
Our initial hypothesis to explain the antiepileptic effects of AN
DBS was that of a stimulation-induced decrease in hippocampal
excitability. This was based on two fold. First, the AN is an
important relay of the limbic circuitry having both direct and
indirect connections with the hippocampus [27,28]. Second, AN
high frequency stimulation in rodents reduces neuronal firing rate
in the hippocampal dentate gyrus [25]. To test this hypothesis, we
recorded DG extracellular activity in slices from epileptic rats that
did or did not receive 5 days of treatment with AN DBS.
Epileptiform events have not been registered at baseline in either
group. When slices were exposed to a zero calcium high potassium
solution, however, DC shifts intermingled with spike discharges
were clearly discriminated (Figure 2A).
Slices from animals previously given DBS at 100 mA had a
longer latency for the development of epileptiform activity
(p = 0.02; p = 0.01), shorter (p = 0.01; p = 0.01) and smaller DC
shifts (p = 0.02; p = 0.01), and a smaller spike amplitude (p = 0.04;
p = 0.02) when compared to those of non-simulated controls and
animals treated with 500 mA, respectively (Figure 2B). In contrast,
slices from animals previously given AN DBS at 500 mA had a
higher spike amplitude as compared to controls
(p = 0.02)(Figure 2B).
Discussion
Our results suggest that AN DBS at a frequency, pulse width
and amplitude that approximate those used in the clinic decreases
seizure rate and reduces hippocampal excitability in chronic
epileptic rats.
In our study, 60% of the animals given stimulation at 100 mA
had a reduction in the number of seizures after receiving DBS.
Further, seizure rate in this group was 61% and 52% lower than
that recorded at baseline or in sham-treated controls. In contrast,
animals given 500 mA had a 500% increase in seizure rate as
compared to controls. Pilocarpine-induced seizures have been
shown to progress over time in both intensity and frequency. To
avoid a significant bias in this regard, we have studied epileptic rats
four months following status, a timeframe during which the
frequency of behavioral seizures in chronic epileptic animals tends
to be more stable [29]. Another factor that deserves to be discussed
is the choice of our control group. In the clinical scenario and in
preclinical paradigms, behavioural changes following the implan-
tation of electrodes (i.e. microlesion effect) are maximal immedi-
ately after surgery. In our study, animals implanted with DBS
Effects of DBS in Chronic Epileptic Rats
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electrodes were given one week to recover from surgery before
stimulation was commenced. During this time, the frequency of
seizures was similar to that recorded in non-implanted controls. As
we did not observe an effect of the insertion of the electrodes at this
time point, we have decided not to pursue further experiments in
sham treated rats with electrodes implanted.
In the only study published to date using AN DBS in chronic
epileptic animals, Lado has studied the frequency of seizures in
rats rendered epileptic following kainic acid injections [21]. He
found that animals had an overall increase in the frequency of
seizures while receiving stimulation. Differences between our study
and his may be explained by the use of different animal models
(pilocarpine vs. kainic acid) and stimulation parameters. Electrodes
in our study had 250 mm in diameter, 0.5 mm of exposed surface,
and an impedance of approximately 1.5–2 MV, while Lado has
used constant voltage stimulation with 7 MV electrodes [21].
Though his output current amplitude was slightly lower than ours
(140–550 mA) [21], with high impedance electrodes Lado was
likely delivering either a higher charge density or influencing a
smaller volume of tissue. In other words, he was likely delivering a
higher current to a smaller volume of tissue. In line with this
conclusion, we found that chronic epileptic rats given DBS at
500 mA had a significant increase in seizure rate.
An important aspect of our study was that 10% of the animals in
the group given DBS at 100 mA had an increase in the frequency
of seizures while receiving stimulation. The location of electrodes
in these animals and the preoperative seizure rate were similar to
those recorded in rats that had an improvement after DBS. At
present, we have not been able to explain these findings. In a
parallel scenario, a few patients reported in clinical trials had an
increase in the frequency of seizures within the first days/weeks of
treatment [5].
Our results expose an important aspect of chronic epileptic
models, that is, the marked variability observed in the frequency of
spontaneous recurrent seizures [29]. Even with a 52% difference
in seizure rate between animals receiving 100 mA and non-
stimulated controls, we were unable to find significant differences
between groups. Seizure severity also seemed to be similar across
groups, though we have only recorded tonic/clonic/tonic-clonic
events that ultimately led to falls. In contrast to these findings,
measures of variability in our electrophysiological experiments
were not as pronounced. In fact, differences across groups could be
easily detected and quantified. This suggests that better strategies
to measure the effects of DBS in vivo are still needed. Alternatives
could be the quantification of electrographic seizures and interictal
spikes. Whether these will provide a more appropriate metric for
studying the effects of DBS in rats remains to be demonstrated.
In addition to the reasons described in the methods section, a
few additional aspects regarding stimulation settings need to be
discussed in further detail. Though bipolar stimulation has been
used in recent clinical trials [5], most applications of DBS use
monopolar stimulation. Provided a similar electrode is used, both
configurations generate different stimulation fields (one is more
spherical and the other pear-shaped). In animal models, we have
Figure 2. Effects of anterior thalamic nucleus (AN) stimulation in vitro. (A) Dentate gyrus extracellular activity in slices from chronic epileptic
rats previously given sham surgery (n = 7), AN DBS at 100 mA (n = 9) or 500 mA (n = 5). When slices from different groups were perfused with a zero
calcium high potassium solution, DC shifts intermingled with spiking discharges were promptly recorded. (B) Overall, slices from animals previously
given DBS at 100 mA had a longer latency for the development of epileptiform activity, shorter and smaller DC shifts, and a smaller spike amplitude as
compared to those from animals previously given no stimulation or DBS at 500 mA. In contrast, a higher spike amplitude was detected in slices from
rats that had AN stimulation at 500 mA. * Statistically significant (p#0.05) as compared to controls. # Statistically significant (p#0.05) as compared to
animals in the other DBS group.
doi:10.1371/journal.pone.0097618.g002
Effects of DBS in Chronic Epileptic Rats
PLOS ONE | www.plosone.org 4 June 2014 | Volume 9 | Issue 6 | e97618
shown that the use of monopolar or bipolar stimulation did not
influence the development pilocarpine-induced seizures or status
epilepticus [14]. In this context, we find it unlikely that the use of
bipolar stimulation in chronic epileptic rats might have signifi-
cantly altered our findings. Another aspect is the use of constant
current versus constant voltage. In theory, constant current (as
used in our study) is much more reliable and theoretically more
appropriate. Older stimulators used in most clinical trials are
limited in this regard. In practical terms, the main disadvantage of
constant voltage occurs in the first weeks/months of programming,
while the impedance of the electrodes fluctuates. After this phase,
both systems seem to be equivalent. Finally, in contrast to the
clinical scenario in which patients receive constant DBS, animals
in our study were stimulated for 6 h/day. Our current DBS system
is external (i.e. animals are connected to stimulators through
cables), which is sometimes problematic when animals develop
seizures. In this sense, our experiments have always been
conducted during the day, under the direct supervision of one of
the investigators. It is possible that a more striking effect could
have been observed if animals were continuously stimulated.
Previous reports have shown that electrical stimulation can
abort seizures in animal models of epilepsy and humans [8,15].
Rather than studying the direct consequences of stimulation in
vitro, we decided to investigate functional changes associated with
DBS given to chronic epileptic rats prior to electrophysiological
experiments. Using this approach we expected to show that, in
addition to the previously demonstrated disruption in seizure
progression [8,15], DBS could also induce a state of lower
excitability and susceptibility for the development of ictal events.
We decided to focus on the hippocampus rather than the AN as
both structures are interconnected relays of the limbic circuitry
[27,28] and AN DBS has been shown to reduce DG firing rate in
rodents [25]. When perfused with artificial CSF, epileptiform
activity has not been recorded in slices from any of the tested
groups. Significant differences, however, were noticed when slices
from groups previously given DBS or sham treatment were
exposed to a zero calcium high potassium solution. As in our
behavioral experiments, we found that stimulation at 100 mA was
protective, whereas 500 mA was proconvulstant. Though we did
not explore mechanisms for the effects of DBS, the fact that the
reduced excitability of DG cells was recorded when slices were
exposed to a zero calcium solution suggest that non-synaptic
mechanisms may play a role. Computer simulation studies have
shown that in slices bathed with the solution used in our study, the
transition from interictal to ictal states is dependent on the activity
of Na+/K+ ATPase [26]. One of the potential mechanisms of
DBS could then be to increase the activity of this enzyme, which
would then lead to a reduction in hippocampal excitability.
Though this has not been demonstrated so far, the administration
of electrical stimulation to both thalamic and hippocampal slices
from naı¨ve animals does induce ATP and adenosine release [30–
33]. These however, are only theoretical considerations that need
to be proven in further experiments.
Conclusions
In summary, we show that AN DBS at specific settings reduces
the frequency of seizures and hippocampal excitability in chronic
epileptic rodents. This may give us a basis to further investigate
biological substrates of this therapy and understand how DBS
works.
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